Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicMice, Inbred C57BLBone Marrow DiseasesKidney TransplantationHematopoiesisRecurrenceSevere Combined ImmunodeficiencyCombined Modality TherapyRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteTime FactorsImmunologic Deficiency SyndromesT-LymphocytesImmunosuppressive AgentsTreatment OutcomeGraft RejectionRemission InductionHematologic NeoplasmsBone RemodelingPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseImmunosuppressionTransplantation ImmunologyBone Marrow NeoplasmsLymphocyte DepletionGraft vs Host ReactionLeukemia, MyeloidAcute DiseaseLymphoma, Non-HodgkinStem Cell TransplantationLeukocyte TransfusionHeart TransplantationHLA AntigensChimeraColony-Forming Units AssaySurvival AnalysisRetrospective StudiesMyelodysplastic SyndromesLung TransplantationSpleenMice, Inbred BALB CCyclosporineBone DensityHematologic DiseasesLymphocyte TransfusionActuarial AnalysisLeukocyte CountCell DifferentiationCytomegalovirus InfectionsNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsFlow CytometryImmune SystemCells, CulturedOrgan TransplantationMice, KnockoutCarmustineFollow-Up StudiesPancytopeniaGraft vs Tumor EffectGraft vs Leukemia EffectSurvival RateCytarabineBone ResorptionGranulocyte Colony-Stimulating FactorImmune ToleranceLymphomaAcquired Immunodeficiency SyndromeMelphalanDisease-Free SurvivalOpportunistic InfectionsInfectionEtoposideMultiple MyelomaFatal OutcomeThymus Gland